Integrating Neurogen Into Preventive Care Workflows

Alzheimer’s preventive care is entering a new era, and we see the same challenge that clinicians face every day: patients want answers long before traditional diagnostic pathways can provide them.

At Neurogen, we’re closing that gap. Our goal is to make proactive memory health accessible in the moments that matter most by providing support and answers about the early signs that families bring to you.

This guide walks you through how our platform integrates into your preventive care workflows, enabling you to deliver clearer guidance, earlier detection, and more empowered patient care.

Why Preventive Alzheimer’s Care Needs a New Approach

When we talk with clinicians, the message is consistent: preventive Alzheimer’s care relies on early, objective insight, but the current system makes that difficult. Imaging wait times, specialist bottlenecks, and subjective assessments limit your ability to intervene early.

We built Neurogen to help solve these challenges by putting evidence-based, accessible testing directly in your hands.

These are some of the key barriers in today’s preventive care workflows:

• Limited access to specialized imaging
• Long referral timelines
• Lack of standardized risk assessment tools
• Time constraints in primary care settings

Plasma biomarkers are helping shift this landscape, and Neurogen’s memory health ecosystem helps make that science clinically practical.

The Role of Plasma Biomarkers in Modern Preventive Care

Plasma biomarkers, especially p-tau217, allow clinicians to detect Alzheimer’s-related changes through a simple blood test. They reduce patient burden, improve access, and offer a level of clarity that previously required advanced imaging.

We’ve aligned our process with these scientific breakthroughs because they fit the realities of primary care and preventive workflows.

Why clinicians are adopting plasma biomarkers for Alzheimer’s detection:

• Rapid clinical utility
• Lower patient burden
• High diagnostic accuracy
• Suitable for routine monitoring

How Neurogen Builds on This Science

Our platform is built directly on peer-reviewed research, including work overseen and validated by our Chief Scientific Officer, Dr. Elisabeth Thijssen.

We’ve taken complex biomarker science and turned it into a clinician-friendly model, supported by transparent reporting and efficient integration.

What Makes Neurogen Clinician-Friendly

We created Neurogen to support your workflow, not disrupt it. Every step is designed to minimize friction, from ordering the test to communicating results to patients and their families.

Core features that we designed for physician workflows:

• Simple ordering and onboarding
• Clear, actionable reports
• Fast turnaround times
• Clinician education + patient communication tools

Our goal is to make early memory health assessment as seamless as checking cholesterol or blood pressure.

Step-by-Step: How to Integrate Neurogen Into Your Preventive Care Workflow

Here’s how Neurogen fits into your current approach to preventive care by supporting the patients who come to you with memory concerns.

Step 1: Identify Patients Who May Benefit From Additional Evaluation

When a patient shares new memory concerns, reports subjective cognitive changes, or has risk factors such as family history, clinicians can recommend that they take Neurogen’s preliminary screening.

This preliminary phase helps determine whether they qualify for biomarker testing and allows them to enter the Neurogen pathway.

Step 2: Guide Patients Toward Neurogen’s At‑Home Testing Process

If a patient qualifies, they can order a test kit and become part of the Neurogen ecosystem. From there, patients schedule an at‑home blood draw with a licensed phlebotomy team — or soon, use a Tasso device for at‑home collection — making the process simple and accessible.

Clinicians don’t need to manage logistics or coordinate lab work. Patients handle the steps directly through Neurogen, which keeps the process efficient for both sides.

Step 3: Receive Results From Neurogen’s Neurology Team

Once the sample is sent to the lab, Neurogen’s neurology team reviews the biomarker results.

If there are signs of elevated biomarker levels, patients meet virtually with a Neurogen neurologist to review the findings, ask questions, and understand what the results mean for their long-term brain health.

From there, they receive a clear, shareable report to share with you during follow-up visits for care planning, preventive treatment, and ongoing discussions about memory health.

Step 4: Use Neurogen Results to Accelerate Continuing Care

Once patients receive their biomarker results through Neurogen’s neurology team, clinicians can move directly into continuing care rather than waiting years for symptoms to progress.

With earlier, objective evidence in hand, you can initiate care planning sooner and with greater confidence — often up to 4.5 years before traditional pathways would trigger a follow-up.

Clinicians can use Neurogen results to:

• Connect patients with appropriate lifestyle, cognitive, or medical interventions
• Determine whether earlier referrals to neurology, memory specialists, or behavioral health are warranted
• Establish a monitoring plan tailored to the patient’s risk profile
• Document clear, objective findings that guide long-term decision‑making

This shift allows you to support patients proactively rather than reactively. By integrating validated biomarker data into your preventive care approach, you can provide earlier reassurance, clearer direction, and a more structured pathway for ongoing care.

How Neurogen Enhances Communication With Patients and Families

We know memory health can spark strong emotions. That’s why we designed our neurologist telehealth visits and test reports to support calm, clear conversations that provide patients and their families with a sense of direction rather than fear.

Benefits for patients and caregivers who join the Neurogen ecosystem:

• Direct communication with a board-certified neurologist
• Clear explanations in accessible language
• Actionable insights without overwhelming science
• More informed long-term planning

Why Physicians Choose Neurogen Over Traditional Alzheimer’s Testing Options

Traditional Alzheimer’s testing relies heavily on imaging, referrals, and wait times, creating delays that don’t align with patients seeking proactive answers.

By contrast, we provide clinicians with a prevention-first pathway that integrates seamlessly into everyday care.

Neurogen vs. Traditional Testing Models:

• Neurogen: Fast, accessible, proactive
• Imaging-first models: High cost, delayed access
• Referral-dependent models: Bottlenecks, long waits

We designed Neurogen to enable you to bring memory health conversations into primary care without added burden.

The Future of Alzheimer’s Preventive Care Starts With Scalable Workflows

We believe preventive Alzheimer’s care should be practical, accessible, and empowering for both clinicians and patients.

By bringing validated biomarker testing into routine care, you can intervene earlier, guide patients more confidently, and offer a more straightforward long-term path.

If you’d like support in integrating Neurogen into your preventive care workflow, our team is here to help.